MX2022010079A - Metodos para preparar derivados quirales de benzodiazepinona. - Google Patents

Metodos para preparar derivados quirales de benzodiazepinona.

Info

Publication number
MX2022010079A
MX2022010079A MX2022010079A MX2022010079A MX2022010079A MX 2022010079 A MX2022010079 A MX 2022010079A MX 2022010079 A MX2022010079 A MX 2022010079A MX 2022010079 A MX2022010079 A MX 2022010079A MX 2022010079 A MX2022010079 A MX 2022010079A
Authority
MX
Mexico
Prior art keywords
sup
sub
compound
integer
formula
Prior art date
Application number
MX2022010079A
Other languages
English (en)
Spanish (es)
Inventor
Christopher M Cimarusti
Anandkumar Madanlal Lahoti
Madan Raja Gopal Reddy Daram
Original Assignee
Ayala Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ayala Pharmaceuticals Inc filed Critical Ayala Pharmaceuticals Inc
Publication of MX2022010079A publication Critical patent/MX2022010079A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/26Preparation from compounds already containing the benzodiazepine skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/30Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MX2022010079A 2020-02-16 2021-02-16 Metodos para preparar derivados quirales de benzodiazepinona. MX2022010079A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062977316P 2020-02-16 2020-02-16
PCT/US2021/018137 WO2021163676A1 (en) 2020-02-16 2021-02-16 Methods of preparing chiral benzodiazepinone derivatives

Publications (1)

Publication Number Publication Date
MX2022010079A true MX2022010079A (es) 2022-09-02

Family

ID=77291712

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010079A MX2022010079A (es) 2020-02-16 2021-02-16 Metodos para preparar derivados quirales de benzodiazepinona.

Country Status (11)

Country Link
US (2) US12503449B2 (https=)
EP (1) EP4107148A4 (https=)
JP (1) JP2023513731A (https=)
KR (1) KR20220143094A (https=)
CN (1) CN115103836A (https=)
AU (1) AU2021218456A1 (https=)
BR (1) BR112022016249A2 (https=)
CA (1) CA3171651A1 (https=)
IL (1) IL295572A (https=)
MX (1) MX2022010079A (https=)
WO (1) WO2021163676A1 (https=)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0253571B1 (en) * 1986-07-14 1989-08-23 Merck & Co. Inc. Process for resolution and race mization of amines with acidic alpha-hydrogens
NL9000386A (nl) * 1990-02-16 1991-09-16 Stamicarbon Werkwijze voor de bereiding van optisch aktief aminozuuramide.
JPH0751555B2 (ja) 1992-04-15 1995-06-05 キヤノン株式会社 ジイモニウム塩化合物
BRPI0520554A2 (pt) * 2005-09-19 2009-06-13 Arrow Therapeutics Ltd uso de uma benzodiazepina ou um sal farmaceuticamente aceitável do mesmo, método para tratar ou prevenir uma infecção por hcv em um paciente, derivado de benzodiazepina ou um sal famaceuticamente aceitável do mesmo, e, composição farmacêutica
WO2010073253A1 (en) 2008-12-22 2010-07-01 Natco Pharma Limited Method for preparing an optically active frovatriptan
WO2013148554A1 (en) * 2012-03-30 2013-10-03 Merck Sharp & Dohme Corp. Process for preparing fluoroleucine alkyl esters
CN105308030A (zh) * 2012-09-21 2016-02-03 百时美施贵宝公司 烷基、氟烷基-1,4-苯并二氮杂*酮化合物
EP2897942B1 (en) 2012-09-21 2016-08-31 Bristol-Myers Squibb Company Fluoroalkyl and fluorocycloalkyl 1,4-benzodiazepinone compounds as notch inhibitors
WO2014047392A1 (en) 2012-09-21 2014-03-27 Bristol-Myers Squibb Company Fluoroalkyl-1,4-benzodiazepinone compounds
TWI614238B (zh) * 2012-09-21 2018-02-11 必治妥美雅史谷比公司 雙(氟烷基)-1,4-苯并二氮呯酮化合物及其前藥
JP6687596B2 (ja) 2015-02-17 2020-04-22 アモーレパシフィック コーポレーションAmorepacific Corporation N−[4−(1−アミノエチル)−フェニル]−スルホンアミド誘導体のキラル分割方法
CN105439939B (zh) 2015-11-12 2018-12-04 四川恒康科技发展有限公司 一种(S)-N-Boc-3-羟基哌啶的合成方法

Also Published As

Publication number Publication date
CN115103836A (zh) 2022-09-23
US20250346565A1 (en) 2025-11-13
BR112022016249A2 (pt) 2022-10-11
CA3171651A1 (en) 2021-08-19
EP4107148A1 (en) 2022-12-28
WO2021163676A1 (en) 2021-08-19
EP4107148A4 (en) 2024-05-15
IL295572A (en) 2022-10-01
US20230108536A1 (en) 2023-04-06
US12503449B2 (en) 2025-12-23
AU2021218456A1 (en) 2022-09-22
KR20220143094A (ko) 2022-10-24
JP2023513731A (ja) 2023-04-03

Similar Documents

Publication Publication Date Title
EP0945440A4 (en) AMINOPYRAZOLE DERIVATIVES
KR100257619B1 (en) Azole compounds, their production and use
KR930017904A (ko) 축합 이미다조피리딘 유도체
YU10192A (sh) Postupak za dobijanje derivata imidazola, triazola i tetrazola
YU51400A (sh) Derivati 2-piridilmetilamina, kao korisni fungicidi
AR035401A1 (es) El uso de compuestos derivados de feniletenilo y feniletinilo; compuestos derivados de feniletinilo; compuestos derivados de feniletenilo; un procedimiento para la elaboracion de los mismos; y medicamentos que los contienen
HUT43927A (en) Fungicides comprising azole derivatives as active substance and process for preparing such derivatives
DE69413542D1 (de) Perhydroisoindolderivate als substanz p antagonisten
ES2094218T3 (es) Derivados de 2-nitroimidazol, su fabricacion, y agente radiosensibilizante que lo incluye como principio activo.
PT1256576E (pt) Derivados de imidazolio fundidos
MX2022010079A (es) Metodos para preparar derivados quirales de benzodiazepinona.
EP0945439A4 (en) AMINOPYRAZOLE DERIVATIVES
KR900004316A (ko) 요오드화물과 회합된 모노히드록시인돌에 의한 케라틴 섬유염색방법 및 사용한 조성물
ATE18218T1 (de) Antifungische triazolyl-propanol-derivate.
WO2000036061A3 (de) Teilchenförmig konfektionierte acetonitril-derivate als bleichaktivatoren in festen reinigungsmitteln
AR054831A1 (es) Derivados de heptaazafenaleno, procedimientos para su obtencion, asi como utilizacion de los mismos como agentes protectores contra la radiacion uv
ES2249636T3 (es) Triazoles como antagonistas de la oxitocina.
PT77975A (en) Process for preparing triazole antifungal agents
ES8504433A1 (es) Un procedimiento para la preparacion de nuevos derivados de triazol con actividad antifungica.
NO165541C (no) Nye azolylderivater, fungicide preparater inneholdende disse som aktiv fugicid bestanddel og anvendelse av azolylderivater for bekjempelse av fungusinfeksjoner i nytteplanter
GB1325761A (en) 2,4,5-trichloro-and 2,4,5-tribromoimidazole derivatives and pesticidal compositions containing them
KR930023031A (ko) 아졸 유도체를 함유하는 항아로마타제제
IL40218A (en) 1,2,4-thiadiazole derivatives,their preparation and their use as biocides
DE59706320D1 (de) Flüssiges wäschestärke-konzentrat
CA2044210A1 (en) Compositions containing nitroaniline dyes having a carbamide substituent group